Mutation analysis of the PMP22, MPZ, EGR2, LITAF, and GJB1 genes in Korean patients with Charcot-Marie-Tooth neuropathy type 1 [2]

Clinical Genetics

Volumn 70, Issue 3, 2006, Pages 253-256

  Park, H K ^a   Kim, B J ^a   Sung, D H ^a   Ki, Chang Seok ^a   Kim, J W ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 32; EARLY GROWTH RESPONSE FACTOR 2; LIPOPOLYSACCHARIDE INDUCED TUMOR NECROSIS FACTOR ALPHA FACTOR; PERIPHERAL MYELIN PROTEIN 22; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; GENE DUPLICATION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN CELL; INTRON; KOREA; LETTER; MUTATIONAL ANALYSIS; NERVE BIOPSY; PATHOGENESIS; PATIENT REFERRAL; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; SOUTHERN BLOTTING;

ADOLESCENT; ADULT; CHARCOT-MARIE-TOOTH DISEASE; CHILD; CONNEXINS; DNA MUTATIONAL ANALYSIS; EARLY GROWTH RESPONSE PROTEIN 2; HUMANS; KOREA; MALE; MUTATION; MYELIN P0 PROTEIN; MYELIN PROTEINS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 33747114287     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2006.00669.x     Document Type: Letter

References (14)

1. Shy ME, Garbern JY, Kamholz J. Hereditary motor and sensory neuropathies: A biological perspective. Lancet Neurol 2002: 1: 110-118.
2. Patel PI, Lupski JR. Charcot-Marie-Tooth disease: A new paradigm for the mechanism of inherited disease. Trends Genet 1994: 10: 128-133.
3. Lupski JR, Wise CA, Kuwano A et al. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992: 1: 29-33.
4. Raeymaekers P, Timmerman V, Nelis E et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord 1991: 1: 93-97.
5. Roa BB, Garcia CA, Suter U et al. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 1993: 329: 96-101.
6. Hayasaka K, Himoro M, Sato W et al. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet 1993: 5: 31-34.
7. Bergoffen J, Scherer SS, Wang S et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993: 262: 2039-2042.
8. Warner LE, Mancias P, Butler IJ et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998: 18: 382-384.
9. Street VA, Bennett CL, Goldy JD et al. Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 2003: 60: 22-26.
10. Kennerson ML, Gordon MJ, Blair IP, Nicholson GA. Single test for two hereditary neuropathies, CMT1A and HNPP. Clin Chem 1995: 41: 1534-1535.
11. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980: 103: 259-280.
12. Nelis E, Van Broeckhoven C, De Jonghe P et al. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: A European collaborative study. Eur J Hum Genet 1996: 4: 25-33.
13. Mostacciuolo ML, Righetti E, Zortea M et al. Charcot-Marie-Tooth disease type I and related demyelinating neuropathies: Mutation analysis in a large cohort of Italian families. Hum Mutat 2001: 18: 32-41.
14. Choi BO, Lee MS, Shin SH et al. Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients. Hum Mutat 2004: 24: 185-186.